Evidence map›Paper›PMID 40799432›Full record

ArticleTranslational lung cancer research2025

Overexpression of

Guangmin Xi, Caibo Zhang, Cong Yu, Yiya Wang, Jinfeng Fu, Haining Qi, Kenichi Suda, Guoying Wu

Abstract read
In one paragraph

Article in Translational lung cancer research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Guangmin XiSchool of Life Sciences, Qilu Normal University, Jinan, China.
Caibo ZhangSchool of Life Sciences, Qilu Normal University, Jinan, China.
Cong YuSchool of Life Sciences, Qilu Normal University, Jinan, China.
Yiya WangSchool of Life Sciences, Qilu Normal University, Jinan, China.
Jinfeng FuCollege of Life and Geographic Sciences, Kashi University, Kashi, China.
Haining QiObstetrical Department, The Affiliated Hospital of Shandong University of TCM, Jinan, China.
Kenichi SudaDivision of Thoracic Surgery, Izumi City General Hospital, Izumi, Japan.
Guoying WuSchool of Life Sciences, Qilu Normal University, Jinan, China.ORCID https://orcid.org/0000-0002-5732-4300

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Lung adenocarcinoma (LUAD) is one of the most malignant types of cancer with a high incidence. Protein phosphatase, Mg Methods: We analyzed the expression profile of Results: Conclusions: Our results revealed that high

Indexed as

glycolysisLung adenocarcinoma (LUAD)NOTCH signaling pathwayPPM1G

Identifiers

PMID40799432
PMCPMC12337070

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.